Une décennie en six valeurs Les Échos Mais l'échec de la pilule anti-obésité Acomplia , finalement abandonnée fin 2008, et la gestion jugée mauvaise de Gérard Le Fur, nommé début 2007 et débarqué ...

RTT News Takeda Snags Orexigen's Obesity Drug in $1B-Plus Deal BioWorld Online Acomplia is not approved in the US and was withdrawn from the FDA registration process in 2007 after negative feedback from an FDA advisory panel. ... Another Japanese Pharma Lays Claim to Diet-Pill Market Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb

Liverpool New Boys Unveiled (Video) CaughtOffside (blog) Generic Acomplia : More Effective With Exercise , Safety of Sildenafil Feminine , Viagra side effects , Nexium: Negating the Ill-effects of Ulcers , More and ...

The new diet pills: fad, fact or fiction? MarketWatch A couple of years ago, Sanofi-Aventis finally abandoned its weight-loss drug Acomplia , also known as rimonabant, after European and US regulators voiced ...

News Northeastern New weight-loss compound shows promise News Northeastern Acomplia , a popular weight-loss drug in Britain, was taken off the shelves after a number of users died and hundreds of others experienced psychological ...

The Case Of Acomplia Highlights The Importance Of Genetic Testing Pharmaceuticals & Healthcare Insight (registration) Acomplia was once one of Sanofi-Aventis's potential blockbuster drugs, with annual sales forecast to be more than US$5bn by 2010 - especially as the ...

Uji Genetika, Selamatkan Obat Penurun Berat Badan Berita8 Acomplia , yang secara generik disebut rimonabant, memblokade reseptor hadiah di dalam otak yang menjadi aktif saat menggunakan mariyuana, ...

Trial for diet pill halted early after suicides msnbc.com It was never licensed in the United States, but was sold as Acomplia , Riobant, Slimona, as well as under other names in Europe. The drug targets certain ... Fake Acomplia analysis reveals chemical cocktail Gene "may have shown Acomplia risk" Genomics might have rescued Sanofi diet drug -

Setbacks in Diet Pill Study New York Times (blog) In 2008 the drug was taken off the market in Europe, where it was being sold under the name Acomplia . Because of the suicide risk, the trial testing the ...